Previous Page  20 / 33 Next Page
Information
Show Menu
Previous Page 20 / 33 Next Page
Page Background

Volume 4

Nano Research & Applications

ISSN: 2471-9838

Page 41

Notes:

August 16-18, 2018 | Dublin, Ireland

&

JOINT EVENT

12

th

Edition of International Conference on

Nanopharmaceutics and Advanced Drug Delivery

25

th

Nano Congress for Future Advancements

Nano Congress 2018

&

Nano Drug Delivery 2018

August 16-18, 2018

Smart biomimetic nanoparticles: A new platform for nanomedicine

T

he ever increasing need of more effective and targeted therapies for the treatment of cancer and various degenerative

pathologies is pushingmaterial scientists to develop new solutions associating enhanced safety with smart functionality, also

permitting the establishment of personalized therapeutic approaches. In this respect, the development and use of nanoparticles

is today limited by several factors among which: i) low biodegradability and biocompatibility; ii) toxic by-products; iii)

uncontrolled drug release into the bloodstream; iv) limited cell-target specificity and v) low efficiency in crossing biological

barriers. In this respect a novel apatite based nanoparticle(NPs) have attracted the attention of scientific community for

biological and medical purposes as promising materials in drug or gene delivery, DNA/biomolecules separation, hypothermal

treatment of tumours, contrast agents for imaging, and recently in tissue engineering and theranostic applications. Recently,

novel biomimetic, fully biodegradable and cytocompatible NPs fabricated by doping hydroxyapatite (HA) with Fe ions (FeHA),

avoiding the presence of magnetic secondary phases and coating, were developed and biologically tested as new drug delivery

systems. The wide possibility of surface functionalization of apatitic nanoparticles significantly extends the potential to develop

smart drug carriers with active or passive ability to cross physiological barriers and to reach relevant organs such as the brain,

the lung or the heart.

Biography

Monica Montesi has obtained her PhD in Cellular and Molecular Biology at the University of Bologna and she has 12 years of expertise in cellular and molecular biology

associated to material science for nanotechnology, tissue engineering research and regenerative medicine. She is a scientific coordinator of NanoBioMagnetism Labora-

tory. She is an author of 40 papers published in international journals, several book chapters and more than 30 congress communications. She has been serving as an

Editorial Board Member of international

Journal of Bone and Mineral Metabolism

and Guest Editor of

International Journal of Molecular Sciences

.

monica.montesi@istec.cnr.it

Monica Montesi

National Research Council of Italy, Italy

Monica Montesi, Nano Res Appl 2018, Volume 4

DOI: 10.21767/2471-9838-C3-014